Haideti sa va dau si citatele (din EPA, atentie, nu de la un vanzator de argint coloidal) pe care KRONOS le va intelege daca v-a ajunge intr-un an mai mare si chiar va dori sa le inteleaga. Aviz si altora.
Este in engleza, dar aveti translator pe Google:
"Gaul and Staud (1935) reported 70 cases of generalized argyria following organic and colloidal silver medication, including 13 cases of generalized argyria following intravenous silver arsphenamine injection therapy and a biospectrometric analysis of 10 cases of generalized argyria classified according to the quantity of silver present. In the i.v. study, data were presented for 10 males (23-64 years old) and for two females (23 and 49 years old) who were administered 31-100 i.v. injections of silver arsphenamine (total dose was 4-20 g) over a 2- to 9.75-year period. Argyria developed after a total dose of 4, 7 or 8 g in some patients, while in others, argyria did not develop until after a total dose of 10, 15 or 20 g. In the biospectrometric analysis of skin biopsies from 10 cases of generalized argyria, the authors confirmed that the degree of the discoloration is directly dependent on the amount of silver present. The authors concluded that argyria may become clinically apparent after a total accumulated i.v. dose of approximately 8 g of silver arsphenamine. The book entitled "Argyria. The Pharmacology of Silver" reached the same conclusion, that a total accumulative i.v. dose of 8 gm silver arsphenamine is the limit beyond which argyria may develop (Hill and Pillsbury, 1939). However, since body accumulates silver throughout life, it is theoretically possible for amounts less than this (for example, 4 g silver arsphenamine) to result in argyria. Therefore, based on cases presented in this study, the lowest i.v. dose resulting in argyria in one patient, 1 g metallic silver (4 g silver arsphenamine x 0.23, the fraction of silver in silver arsphenamine) is considered to be a minimal effect level for this study.
Blumberg and Carey (1934) reported argyria in an emaciated chronically ill (more than 15 years) 33-year-old female (32.7 kg) who had ingested capsules containing silver nitrate over a period of 1 year. The patient reported ingesting 16 mg silver nitrate three times a day (about 30 mg silver/day) for alternate periods of 2 weeks. Spectrographic analysis of blood samples revealed a blood silver level of 0.5 mg/L 1 week after ingestion of silver nitrate capsules ceased, and there was only a small decrease in this level after 3 months. The authors noted that this marked argyremia was striking because even in cases of documented argyria, blood silver levels are not generally elevated to this extent. Normal levels for argyremic patients were reported to range from not detected to 0.005 mg Ag/l blood. Heavy traces of silver in the skin, moderate amounts in the urine and feces, and trace amounts in the saliva were reported in samples tested 3 months after ingestion of the capsules stopped; however, despite the marked argyremia and detection of silver in the skin, the argyria at 3 months was quite mild. No obvious dark pigmentation was seen other than gingival lines which are considered to be characteristic of the first signs of argyria. The authors suggested that this may have been because the woman was not exposed to strong light during the period of silver treatment. This study is not suitable to serve as the basis for a quantitative risk assessment for silver because it is a clinical report on only one patient of compromised health. Furthermore, the actual amount of silver ingested is based on the patient's recollection and cannot be accurately determined.
In a case reported by East et al. (1980), argyria was diagnosed in a 47-year- old woman (58.6 kg) who had taken excessively large oral doses of anti-smoking lozenges containing silver acetate over a period of 2.5 years. No information was provided as to the actual amount of silver ingested. Symptoms of argyria appeared after the first 6 months of exposure. Based on whole body neutron activation analysis, the total body burden of silver in this female was estimated to be 6.4 (plus or minus 2) g. Both the total body burden and concentration of silver in the skin were estimated to be 8000 times higher than normal. In a separate 30-week experiment, the same subject retained 18% of a single dose of orally-administered silver, a retention level much higher than that reported by other investigators. East et al. (1980) cited other studies on this particular anti-smoking formulation (on the market since 1973) which demonstrated that "within the limits of experimental error, no silver is retained after oral administration." However, this may not hold true for excessive intakes like that ingested by this individual. As with the study by Blumberg and Carey (1934), this study is not suitable to serve as the basis for a quantitative risk assessment. It is a clinical report on only one patient and the actual amount of silver ingested can only be estimated."
Puteti observa despre ce cantitati este vorba, si nu este nici macar o fractie din studiile facute (si relativ inaccesibile). In plus, veti observa ca se refera la compusi de argint, care (in general) se elimina doar pe cale fecala, fiind procesati de catre ficat, CU CONDITIA SA NU FIE INGERATI IN CANTITATI RIDICATE.
5. Sau pe acolo. Sa trecem la chestii mai serioase. Iata niste link-uri pentru cei care repeta ca papagalii. Sunt curios cati dintre papagai sunt interesati sa devina, stiu eu, pasari Phoenix, sau ceva de genul. La unele studii veti avea disponibile doar headerele.
a.
http://www.jnanobiotechnology.com/content/8/1/19
Interaction of silver nanoparticles with Tacaribe virus
Janice L Speshock, Richard C Murdock, Laura K Braydich-Stolle, Amanda M Schrand and Saber M Hussain*
* Corresponding author: Saber M Hussain
saber.hussain@wpafb.af.mil
Author Affiliations
Applied Biotechnology Branch, Human Effectiveness Directorate, 711th Human Performance Wing, U.S. Air Force Research Laboratory, 2729 R Street, Wright-Patterson Air Force Base, OH, 45433-5707, USA
b.
http://www.jnanobiotechnology.com/content/3/1/6
Interaction of silver nanoparticles with HIV-1
Jose L Elechiguerra1, Justin L Burt1, Jose R Morones1, Alejandra Camacho-Bragado2, Xiaoxia Gao2, Humberto H Lara3 and Miguel J Yacaman1,2*
* Corresponding author: Miguel J Yacaman
yacaman@che.utexas.edu
Author Affiliations
1 Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA
2 Texas Materials Institute, The University of Texas at Austin, Austin, Texas 78712, USA
3 Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, Mexico
c.
http://www.ncbi.nlm.nih.gov/pubmed/18505176
Silver nanoparticles inhibit hepatitis B virus replication.
Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM.
Source
Department of Medicine, The University of Hong Kong, Pokfulam Road, Hong Kong, China.
d.
http://www.ncbi.nlm.nih.gov/pubmed/21141805
Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate.
Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R.
Source
Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel.
Asta numai in ceea ce priveste efectul antiviral. Hai sa o dam putin pe cancer.
e.
http://www.ncbi.nlm.nih.gov/pubmed/19698986
Antiangiogenic properties of silver nanoparticles.
Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom SH.
Source
Department of Biotechnology, Division of Molecular and Cellular Biology, Kalasalingam University, Anand Nagar, Krishnankoil 626190, Tamil Nadu, India.
lvsangs@yahoo.com
f.
http://www.ncbi.nlm.nih.gov/pubmed/19836347
Biochem Biophys Res Commun. 2009 Dec 18;390(3):733-7. doi: 10.1016/j.bbrc.2009.10.039. Epub 2009 Oct 21.
Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells.
Miura N, Shinohara Y.
Source
Division of Health Effects Research, National Institute of Occupational Safety and Health (JNIOSH), Kawasaki 214-8585, Japan.
miuran@h.jniosh.go.jp
Si as mai putea sa o tin tot asa, pentru toti atotstiutorii, medici, farmacisti, jurnalisti, etc. A se nota ca toate astea au fost traduse si in limba romana, si daca cineva ar fi dorit sa le gaseasca le-ar fi gasit. ATI DORIT DOMNILOR?
O sa continui insa cu altceva.
6. Sunt binecunoscute numeroasele probleme produse de catre excesul de antibiotice (eu insumi utilizez uneori, dar am un "sistem" inca bine functional, si nu exagerez). Cu toate acestea, imi fac cruce cand aud de "TRATAMENTE" de luni de zile cu antibiotice, in cazuri care uneori par de doi lei. Nu ma refer la Lyme, ci la cazuri de doi lei.
SI VIN CU INTREBAREA: cum pot oare niste fiinte care au depus un juramant la inceperea meseriei (nu stiu farmacistii, dar in cazul medicilor stiu ca asa este), sa recomanda la o viroza respiratorie (AM SPUS VIROZA), sa recomande tratamente cu antibiotice, uneori prelungite, cand SE STIE (sau asa ar trebui, daca nu si-au luat examenele cu spagi), ca antibioticele nu au efect asupra vreunui virus. In fapt, nu se cunoaste un tratament modern pentru cele circa 200 (DOUA SUTE) de tulpini virale care dau virozele respiratorii, ca sa nu mai vorbim de gripe.
Cu exceptia Tamiflu, care este o tampenie cu multe efecte secundare ( a se vedea legaturile cu cazurile de suicid din Japonia), nu exista. E clar ca numeroasele persoane care trateaza virozele respiratorii cu argint coloidal se autoiluzioneaza ca le trece, caci asa cum suntem invatati de mici "raceala trece in 7 zile, tratata sau nu".
Eu personal sunt deja convins ca ma autoiluzionez, cand vad pe mine si pe altii ca argintul coloidal functioneaza. Nu la orice, asa cum spune alta categorie de... profitori, dar in anumite cazuri, in special de natura infectioasa sau virala.